Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 67.35
-0.13 (-0.19%)
Jul 31, 2026, 3:28 PM IST
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.41 billion as of July 31, 2026. Its market cap has decreased by -35.56% in one year.
Market Cap
1.41B
Enterprise Value
52.71M
Revenue
1.06B
Ranking
n/a
PE Ratio
9.37
Stock Price
67.35
ChartMarket Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has increased from 1.15B to 1.41B, an increase of 21.97%. That is a compound annual growth rate of 1.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.41B | -13.97% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jagsonpal Pharmaceuticals | 15.22B |
| Sigachi Industries | 9.90B |
| Bafna Pharmaceuticals | 6.22B |
| Valiant Laboratories | 3.30B |
| Nectar Lifesciences | 2.06B |
| Brooks Laboratories | 1.80B |
| Balaxi Pharmaceuticals | 1.32B |
| Par Drugs and Chemicals | 1.22B |